Raksha Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-07-2024
- Paid Up Capital ₹ 0.10 M
as on 25-07-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -4.76%
(FY 2023)
- Profit -0.81%
(FY 2023)
- Ebitda -2.24%
(FY 2023)
- Net Worth 20.64%
(FY 2023)
- Total Assets 55.28%
(FY 2023)
About Raksha Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Ahire and Shankar Harwani serve as directors at the Company.
- CIN/LLPIN
U24100MH2008PTC181186
- Company No.
181186
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Raksha Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Ahire  | Director | 30-Jun-2012 | Current |
| Shankar Harwani | Director | 10-Nov-2017 | Current |
Financial Performance of Raksha Life Sciences.
Raksha Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.76% decrease. The company also saw a slight decrease in profitability, with a 0.81% decrease in profit. The company's net worth Soared by an impressive increase of 20.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raksha Life Sciences?
In 2023, Raksha Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Heramb Pharmaceuticals Private LimitedActive 9 years 7 months
Atul Ahire and Shankar Harwani are mutual person
- Vkrg Lifesciences Private LimitedActive 3 years 8 months
Atul Ahire and Shankar Harwani are mutual person
- Rhythmed Pharma Private LimitedActive 5 years 1 month
Atul Ahire and Shankar Harwani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Raksha Life Sciences?
Unlock and access historical data on people associated with Raksha Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raksha Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raksha Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
